The study showed those who used wood stoves lost lung capacity more quickly than non-users - even though they tended to be ...

In this episode of the Treating Together podcast, Edward S. Kim, MD, MBA, and Neel Shah, MD, discuss the rapid advancements in lung cancer therapy, the challenges community physicians face in staying ...

Novocure (NASDAQ: NVCR) announced that final results from the Phase 3 METIS trial of Tumor Treating Fields (TTFields) therapy for brain metastases from non-small cell lung cancer (NSCLC) will be ...

Lung cancer remains one of the deadliest cancers worldwide, with survival rates stubbornly low despite advances in surgery, ...

Dr. Sandip Patel discusses findings from a real-world study of biomarker testing in early-stage resected non-small cell lung cancer in the U.S.

Genmab acquires Merus for $8B, boosting cancer drug pipeline with petosemtamab. Check out what this deal means for GMAB and ...

Patients with lung cancer treated with immune checkpoint inhibitors are at significantly higher risk for certain major cardiovascular adverse events. Patients with lung cancer treated with immune ...

Researchers at the University of Oslo and Oslo University Hospital have developed a promising new immunotherapy targeting the ...

An expert discusses how the IMpower133 trial established atezolizumab plus chemotherapy as standard care for extensive-stage small cell lung cancer, improving overall survival from 10.3 to 12.3 months ...

Recent findings suggest CT scans could be a major cancer risk, but some critics don’t think the estimates add up.

These findings indicate that the addition of atezolizumab or durvalumab to platinum-doublet chemotherapy improves the ORR and ...

Robotic bronchoscopy with cold beam CT showed superior diagnostic yield over conventional bronchoscopy in early lung cancer, ...